Dermaliq Therapeutics locks in $15m Series A

Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing.

18 January 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles